We are honored to be named one of Inc. Magazine’s Founder-Friendly Investors for the second consecutive year. The annual list recognizes private equity, venture capital and debt firms with track records of success backing entrepreneurs. ? This recognition reflects our commitment to helping growing businesses achieve their full potential, and promoting better, faster, and more cost-effective health care. ? Learn more about what it means to be a Founder-Friendly investor: https://lnkd.in/eQWQn-Z4
关于我们
Great Point Partners was founded in 2003 with a vision of helping growing health care companies achieve their full potential while improving global health care. Great Point has two distinct teams managing separate but highly complementary investment strategies - lower middle market growth buyout funds investing in private health care companies and a hedge fund investing in public life sciences companies. We recognize the tremendous synergy gained by investing in both private and public companies across the health care spectrum, and companies choose to work with us because of our health care expertise, industry contacts, and focus on helping strong management teams grow their businesses. With offices in Connecticut and London, we are led by a team of Managing Directors with a collective 90+ years of investment experience, supported by over 30 professionals. Our CEO Advisory Board is comprised of leading health care industry executives who have built successful businesses, and our Medical Advisory Board of physicians and scientists who are luminaries in their fields.
- 网站
-
https://www.gppfunds.com
Great Point Partners的外部链接
- 所属行业
- 金融服务
- 规模
- 11-50 人
- 总部
- Greenwich,CT
- 类型
- 合营企业
- 创立
- 2003
地点
-
主要
165 Mason Street
3rd Floor
US,CT,Greenwich,06830
Great Point Partners员工
-
Philippe Van der Hofstadt
Board Member at White Raven, a new flexible CDMO for sterile fill & finish
-
Rohan Saikia
Managing Director at Great Point Partners
-
Lydia Toperzer
Office Manager & Executive Assistant at Great Point Partners, LLC
-
Jeffrey Jay, M.D., M.B.A.
Founder and Managing Partner at Great Point Partners
动态
-
This week, our team will be in attendance at ACG Chicago’s 25th Annual Midwest Capital Connection, where we look forward to engaging with our peers in the investment banking and advisory communities. If you’d like to meet with us onsite, please don’t hesitate to reach out directly.?#ACGChicago
-
Cellipont Bioservices' recent partnership with Mongoose Bio Inc. marks an exciting milestone in the company’s work to deliver novel cell therapies to cancer patients. We’re proud to support the Cellipont team as they continue to advance innovative cancer treatments. ? Read more about their partnership here: https://lnkd.in/eYZ4BXpV
Cellipont Bioservices, a cell therapy CDMO, and Mongoose Bio, a biopharma company pioneering precision T-cell based therapies targeting solid cancers, signed an agreement for the technology transfer, process development, and cGMP manufacture of its autologous MGB-001 TCR-T cell therapy program. https://hubs.li/Q02SXTBJ0
-
One of the health care industry’s largest and most innovative events is fast-approaching, and our team is excited to be onsite: HLTH USA 2024 will take place next week, October 20-23, in Las Vegas. ? We look forward to connecting with some of the brightest minds in global health to explore emerging themes across patient care, policy, emerging technology and more. ? If you plan to attend and would like to schedule a meeting with our team, please reach out.?
-
It was a pleasure to be onsite at Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa last week, a leading event gathering senior decision-makers to discuss commercialization hurdles facing the cell and gene therapy sector today. ? It was great to speak with so many key leaders on topics from clinical trial design to alternative payment models, and we look forward to continuing these important conversations across the industry. Please reach out to our team directly if you are interested in discussing.?#CGMesa24
-
Congratulations to JPA Health on winning Best Integrated Campaign at the International Public Relations Network (IPRN) Awards. We’re excited to see the firm recognized for its iDose TR launch, and its work in raising awareness and bringing innovative treatments to patients with glaucoma.?
We’re excited to share that JPA has won an International Public Relations Network (IPRN) Award for Best Integrated Campaign for our iDose TR launch with Glaukos! The IPRN Awards celebrate the best in the communications industry around the globe, and we’re proud to be recognized for our work with Glaukos to bring innovative treatments to patients living with glaucoma.? Bonus: Here's a photo of JPA Health CEO, Carrie Jones, with IPRN President, Rodrigo Viana de Freitas, capturing a moment of shared vision and partnership. #publicrelationsagency #awardwinningagency #healthcommunications?
-
With over 26 years of experience in biological, device, and drug manufacturing, we’re excited to welcome Darren Head as Chief Executive Officer of Cellipont Bioservices. ? In addition to his role as Chairman of the Board, Darren brings deep institutional knowledge and a wealth of biopharmaceutical leadership experience to the role. We’d like to congratulate Cellipont on this step forward in expanding its executive leadership and operations to continue delivering groundbreaking cell therapies to the market. ? Read the full announcement below.
Press Announcement:?We're pleased to announce Darren Head?as Chief Executive Officer & Minority Growth Equity Investment From HealthQuest Capital. Click here to read the full press release:?https://lnkd.in/eJUt8dsE #NewCEO #CDMO #CTCDMO #Celltherapy #TheWoodlands #News?Great Point Partners?HealthQuest Capital Darren Head
-
We’re looking forward to attending Contract Pharma’s 23rd Annual Contracting & Outsourcing Conference this week, where we expect an impressive line up of speakers and exhibitions addressing key industry topics across manufacturing, packaging, laboratory services, and more. ? Please reach out if you would like to connect onsite.?
-
This week, our team is onsite at the Self-Insurance Institute of America, Inc. National Conference in Phoenix, Arizona. ? We’re excited to be connecting with today’s leaders in the self-insurance marketplace. To schedule a meeting with our team, please reach out directly.
-
Congratulations to the MLM Medical Labs team on the opening of their new, expanded facility in Germany. The company’s continued growth underscores the increasing demand for global clinical trial kits. As the market continues to scale, we look forward to supporting MLM’s mission to add value to every stage of the drug development process and improve patient lives.?
#MOVING IN & UP! Today, MLM - Germany completed the transition into its new expanded facility to accomodate the growing demand in the global clinical trial kits market (expected to eclipse $2.5B by 2030 from $1.6B in 2023*). In line with this rate of growth globally, #MLMKitBuilding? assembles and ships over 100,000 kits worldwide each year - customized to meet each client's specific trial needs! Learn more about the massively important and quantifiable advantages of MLM Kit Building? >> https://lnkd.in/eNmK2KTE #clinicaltrials #kitbuilding #samplemanagement #CRO #centrallab * https://lnkd.in/ek4rte9D